Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$18.01
-0.06-0.33%
Last update: Dec 12, 4:39 PM
Comments
Loading...
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Compare
EPS better than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS better than industry
FAQ
How do I buy Mesoblast (MESO) stock?
You can purchase shares of Mesoblast (NASDAQ:MESO) through any online brokerage.
Who are Mesoblast (MESO) competitors?
Other companies in Mesoblast’s space includes: IDEAYA Biosciences Inc (NASDAQ:IDYA), Twist Bioscience Corp (NASDAQ:TWST), Sarepta Therapeutics Inc (NASDAQ:SRPT), Ascentage Pharma Group International (NASDAQ:AAPG) and Sionna Therapeutics Inc (NASDAQ:SION).
What is the forecast, or price target, for Mesoblast (MESO) stock?
Mesoblast has a consensus price target of $12.50.
What is the current price for Mesoblast (MESO)?
The stock price for Mesoblast (NASDAQ: MESO) is $18.01 last updated December 12, 2025 at 4:39 PM EST.
Does Mesoblast (MESO) pay a dividend?
There are no upcoming dividends for Mesoblast.
When is Mesoblast (NASDAQ:MESO) reporting earnings?
Mesoblast does not have any upcoming earnings scheduled.
Is Mesoblast (MESO) going to split?
There is no upcoming split for Mesoblast.
What sector and industry does Mesoblast (MESO) operate in?
Mesoblast is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
